SGRY (Surgery Partners, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by SGRY officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-20 | Teresa DeLuca | Director | Buy | — | — |
| 2026-08-19 | Teresa DeLuca | Director | Buy | — | — |
| 2026-07-14 | BLAIR E HENDRIX | Director | A | — | — |
| 2026-06-09 | Teresa DeLuca | Director | A | — | — |
| 2026-06-09 | BRENT TURNER | Director | A | — | — |
| 2026-06-09 | BLAIR E HENDRIX | Director | A | — | — |
| 2026-06-09 | CLIFFORD G ADLERZ | Director | A | — | — |
| 2026-06-09 | John A Deane | Director | A | — | — |
| 2026-06-09 | Laura L Forese | Director | A | — | — |
| 2026-06-09 | Lloyd H Dean | Director | A | — | — |
| 2026-03-16 | Jennifer Baldock | Chief Admin & Dev Officer | Sell | — | — |
| 2026-03-16 | Marissa Brittenham | Chief Strategy Officer | Sell | — | — |
| 2026-03-16 | Jason Eric Evans | Chief Executive Officer | Sell | — | — |
| 2026-03-16 | Danielle Burkhalter | Chief Human Resources Officer | Sell | — | — |
| 2026-03-16 | David T Doherty | Chief Financial Officer | Sell | — | — |
| 2026-03-09 | Justin Robert Oppenheimer | COO & National Group President | A | — | — |
| 2026-03-09 | William Trenton Webb | American Group President | MIXED | — | — |
| 2026-03-09 | Danielle Burkhalter | Chief Human Resources Officer | MIXED | — | — |
| 2026-03-09 | Jason Eric Evans | Chief Executive Officer | MIXED | — | — |
| 2026-03-09 | Jennifer Baldock | Chief Admin & Dev Officer | MIXED | — | — |
| 2026-03-09 | Marissa Brittenham | Chief Strategy Officer | MIXED | — | — |
| 2026-03-09 | David T Doherty | Chief Financial Officer | MIXED | — | — |
| 2026-01-15 | Justin Robert Oppenheimer | COO & National Group President | A | — | — |
| 2025-09-08 | Harrison R. Bane | National Group President | Sell | — | — |
| 2025-08-15 | Patricia Anne Maryland | Director | Sell | — | — |
| 2025-08-15 | Teresa DeLuca | Director | Sell | — | — |
| 2025-08-13 | Patricia Anne Maryland | Director | Sell | — | — |
| 2025-08-08 | David T Doherty | Chief Financial Officer | Sell | — | — |
| 2025-06-12 | BRENT TURNER | Director | A | — | — |
| 2025-06-12 | Patricia Anne Maryland | Director | A | — | — |
| 2025-06-12 | CLIFFORD G ADLERZ | Director | A | — | — |
| 2025-06-12 | Laura L Forese | Director | A | — | — |
| 2025-06-12 | John A Deane | Director | A | — | — |
| 2025-06-12 | BLAIR E HENDRIX | Director | A | — | — |
| 2025-06-12 | Teresa DeLuca | Director | A | — | — |
| 2025-03-25 | Wayne S DeVeydt | Exec Chairman of the Board | A | — | — |
| 2025-03-17 | William Trenton Webb | American Group President | Sell | — | — |
| 2025-03-17 | Jennifer Baldock | Chief Admin & Dev Officer | Sell | — | — |
| 2025-03-17 | Danielle Burkhalter | Chief Human Resources Officer | Sell | — | — |
| 2025-03-13 | Marissa Brittenham | Chief Strategy Officer | Sell | — | — |
| 2025-03-13 | Jennifer Baldock | Chief Admin & Dev Officer | Sell | — | — |
| 2025-03-13 | David T Doherty | Chief Financial Officer | Sell | — | — |
| 2025-03-13 | Harrison R. Bane | National Group President | Sell | — | — |
| 2025-03-13 | William Trenton Webb | American Group President | Sell | — | — |
| 2025-03-13 | Danielle Burkhalter | Chief Human Resources Officer | Sell | — | — |
| 2025-03-06 | Danielle Burkhalter | Chief Human Resources Officer | A | — | — |
| 2025-03-06 | Jennifer Baldock | Chief Admin & Dev Officer | A | — | — |
| 2025-03-06 | David T Doherty | Chief Financial Officer | A | — | — |
| 2025-03-06 | Marissa Brittenham | Chief Strategy Officer | A | — | — |
| 2025-03-06 | Jason Eric Evans | Chief Executive Officer | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 58,248,249 | — |
| — | Director | 50,421,379 | — |
| — | Director | 49,999,867 | — |
| — | Director | 49,946,972 | — |
| — | Director | 49,946,972 | — |
| — | 10%+ Owner | 26,455,651 | — |
| — | Chief Executive Officer | 3,122,474 | — |
| — | Chief Executive Officer | 920,386 | — |
| — | Chief Admin & Dev Officer | 326,474 | — |
| — | Chief Financial Officer | 221,679 | — |
| — | Executive VP & CFO | 192,360 | — |
| — | Chief Financial Officer | 143,573 | — |
| — | National Group President | 120,794 | — |
| — | COO & National Group President | 120,259 | — |
| — | Senior VP & Controller | 120,210 | — |
| — | Group Pres., National Group | 113,329 | — |
| — | Exec Chairman of the Board | 105,203 | — |
| — | Chief Growth Officer | 102,321 | — |
| — | Chief Strategy Officer | 94,196 | — |
| — | EVP, COO of SP Ntl Grp | 90,594 | — |
| — | Director | 86,594 | — |
| — | Chief Human Resources Officer | 76,864 | — |
| — | American Group President | 74,249 | — |
| — | National Group President | 72,338 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the SGRY quote page; the site-wide leaderboard is on the insider transactions hub.